Page last updated: 2024-09-03

n(6)-carboxymethyllysine and Coronary Disease

n(6)-carboxymethyllysine has been researched along with Coronary Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Cai, Q; Fang, F; Ji, Y; Li, Y; Liu, W; Zhang, W1
Cardelo, MP; de la Cruz-Ares, S; García-Rios, A; Gutiérrez-Mariscal, FM; Katsiki, N; López-Miranda, J; Malagón, MM; Pérez-Martínez, P; Torres-Peña, JD; Yubero-Serrano, EM1
Arnold, AM; Benkeser, D; Djousse, L; Ix, JH; Kizer, JR; Mukamal, KJ; Psaty, BM; Siscovick, DS; Tracy, RP; Zieman, SJ1
Dworacka, M; Szczawińska, K; Szymańska, M; Wierusz-Wysocka, B; Winiarska, H1
Berg, TJ; Birkeland, KI; Hanssen, KF; Kilhovd, BK; Thorsby, P1

Trials

3 trial(s) available for n(6)-carboxymethyllysine and Coronary Disease

ArticleYear
Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study.
    Nutrients, 2020, Jan-16, Volume: 12, Issue:1

    Topics: Biomarkers; Carotid Artery Diseases; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diet, Healthy; Endothelium, Vascular; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Olive Oil; Pyruvaldehyde; Single-Blind Method; Vasodilation

2020
Serum N-epsilon-(carboxymethyl)lysine is elevated in nondiabetic coronary heart disease patients.
    Journal of basic and clinical physiology and pharmacology, 2002, Volume: 13, Issue:3

    Topics: Arteriosclerosis; C-Peptide; Carbohydrate Metabolism; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Glucose; Humans; Islets of Langerhans; Lipid Metabolism; Lipoproteins, HDL; Lysine; Male; Middle Aged; Oxidation-Reduction

2002
Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.
    Diabetes care, 1999, Volume: 22, Issue:9

    Topics: Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Epitopes; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Multivariate Analysis; Risk Factors

1999

Other Studies

2 other study(ies) available for n(6)-carboxymethyllysine and Coronary Disease

ArticleYear
Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease.
    Computational intelligence and neuroscience, 2022, Volume: 2022

    Topics: Atherosclerosis; Biomarkers; Coronary Disease; Glycation End Products, Advanced; Humans; Lysine; Receptor for Advanced Glycation End Products

2022
Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults.
    Atherosclerosis, 2014, Volume: 235, Issue:1

    Topics: Aged; Albumins; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Cohort Studies; Coronary Disease; Creatinine; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Immunoassay; Incidence; Lysine; Male; Oxidative Stress; Proportional Hazards Models; Stroke; Treatment Outcome

2014